| mRNA |
salermide:PLX-4032 (12:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.24 |
4e-09 |
| mRNA |
dabrafenib |
CTRPv2 |
pan-cancer |
AAC |
0.34 |
1e-08 |
| mRNA |
navitoclax:PLX-4032 (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.18 |
3e-06 |
| mRNA |
PLX4720 |
CTRPv2 |
pan-cancer |
AAC |
0.17 |
1e-05 |
| mRNA |
PLX4720 |
CCLE |
pan-cancer |
AAC |
0.22 |
2e-05 |
| mRNA |
serdemetan:SCH-529074 (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.16 |
5e-05 |
| mRNA |
BRD-K28456706 |
CTRPv2 |
pan-cancer |
AAC |
0.16 |
8e-05 |
| mRNA |
BRD-K88742110 |
CTRPv2 |
pan-cancer |
AAC |
0.16 |
9e-05 |
| mRNA |
EKB-569 |
GDSC1000 |
pan-cancer |
AAC |
-0.14 |
0.0002 |
| mRNA |
lapatinib |
GDSC1000 |
pan-cancer |
AAC |
-0.22 |
0.0002 |